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Background: Mushrooms are not only regarded as gourmet cuisine but also as therapeutic agent to promote
cognition health. However, little toxicological information is available regarding their safety. Therefore, the aim of
this study was to screen selected ethno-pharmacologically important mushrooms for stimulatory effects on neurite
outgrowth and to test for any cytotoxicity.
Methods: The stimulatory effect of mushrooms on neurite outgrowth was assessed in differentiating mouse
neuroblastoma (N2a) cells. Neurite length was measured using Image-Pro Insight processor system. Neuritogenesis
activity was further validated by fluorescence immunocytochemical staining of neurofilaments. In vitro cytotoxicity
was investigated by using mouse embryonic fibroblast (BALB/3T3) and N2a cells for any embryo- and neuro-toxic
effects; respectively.
Results: Aqueous extracts of Ganoderma lucidum, Lignosus rhinocerotis, Pleurotus giganteus and Grifola frondosa; as
well as an ethanol extract of Cordyceps militaris significantly (p < 0.05) promoted the neurite outgrowth in N2a cells
by 38.4 ± 4.2%, 38.1 ± 2.6%, 33.4 ± 4.6%, 33.7 ± 1.5%, and 35.8 ± 3.4%; respectively. The IC50 values obtained from
tetrazolium (MTT), neutral red uptake (NRU) and lactate dehydrogenase (LDH) release assays showed no toxic
effects following 24 h exposure of N2a and 3T3 cells to mushroom extracts.
Conclusion: Our results indicate that G. lucidum, L. rhinocerotis, P. giganteus, G. frondosa and C. militaris may be
developed as safe and healthy dietary supplements for brain and cognitive health.
Keywords: Culinary-medicinal mushrooms, Neurite outgrowth, Cytotoxicity, Mouse neuroblastoma N2a cell,
Mouse 3T3 embryonic fibroblast, NeurofilamentBackground
Neurite outgrowth is an important event in neuronal path
finding and the establishment of synaptic connections
during development [1,2]. It is also essential in neuronal
plasticity, neuronal regeneration after injury [3,4] and
neurodegenerative conditions such as Alzheimer’s and
Parkinson’s diseases [5]. Therefore, treatments aiming at* Correspondence: rosiepamela@um.edu.my
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reproduction in any medium, provided the orpromoting neurite outgrowth and preserving the neurite
network and synaptic connections are needed.
The potential use of culinary-medicinal mushrooms in
neurodegenerative diseases is being explored [6]. On-going
research in our laboratory shows that Hericium erinaceus
(Bull.: Fr) Pers. (monkey’s head mushroom, lion’s mane
mushroom and Yamabushitake) [7], Lignosus rhinocerotis
(Cooke) Ryvarden (tiger milk mushroom) [8,9], and
Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde
(morning glory mushroom, cow’s stomach mushroom)
[10] exhibit neurite outgrowth stimulatory effects in
NG108-15 and PC12 cell lines. This observation raised a
question with respect to the neurodevelopmental effects,d. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have been identified as a growing social and healthcare
issue. Congenital diseases are present in 2–3% of human
newborns [11]. About 20% of the birth defects are due to
genetic anomaly and 10% are caused by environmental
factors during pregnancy [12]. Therefore, toxicological
safety assessments of food, chemicals and drugs to evaluate
the effects on reproductive health and for embryotoxicity
have become an important requirement. Thus, the aims of
the present study were (a) to evaluate neurite outgrowth
stimulatory effects of selected culinary-medicinal mush-
rooms using neuroblastoma-2a (N2a) cells and (b) to
assess the neuro- and embryotoxicity of the mushroom
extracts using N2a and 3T3 fibroblasts. The results will
enable us to select potential mushrooms for further in
depth in vivo developmental toxicity evaluation.Methods
Mushroom and plant samples
The mushrooms were authenticated by experts in the
Mushroom Research Centre, University of Malaya and
voucher specimens were deposited in the University of
Malaya herbarium at Rimba Ilmu (Table 1). Fresh fruiting
bodies of Ganoderma lucidum (Fr) P. Karst (KLU-M 1233)
and H. erinaceus (KLU-M 1232) were obtained from
Ganofarm Sdn Bhd. Pleurotus giganteus (KLU-M 1227)
was provided by Nas Agro Farm and Dong Foong Biotech.
Freeze dried powder of Cordyceps militaris (L.:Fr.) Link
and L. rhinocerotis were purchased from BioFact Life Sdn
Bhd and Ligno Biotek Sdn Bhd, respectively. Pleurotus
pulmonarius (Fr.) Quél. (KLU-M 1309) and Gingko biloba
extracts were obtained from Reishilab Sdn Bhd, Selangor.
Wild Ganoderma neo-japonicum Imazeki 1939 (KLU-M
1231) was collected from forest in Ulu Grik, Perak,
Malaysia. Ganoderma neo-japonicum was used as trad-
itional medicine by the indigenous people in Malaysia.
Grifola frondosa (Dicks.: Fr.) S.F. Gray (KLU-M 1229)
imported from Japan was obtained from supermarkets
in Selangor, Malaysia. Lycium barbarum (wolfberry),
a traditional Chinese medicine was purchased from a
Chinese medicine shop in Selangor, Malaysia and deposited
in University of Malaya herbarium. Curcumin was pur-
chased from NatXtra, Synthite Co., India.Chemicals
Phosphate buffered saline (PBS), [3-(4,5-dimethythiazol-
2-yl)-2,5-diphenyltetrazolium bromide] (MTT), dimethyl
sulfoxide (DMSO), nerve growth factor (NGF) from mur-
ine submaxillary gland, 3-amino-7-dimethylamino-2-me-
thyl-phenazine hydrochloride (neutral red), and foetal
bovine serum (FBS) were obtained from Sigma Co. (St.
Louis, MO, USA).Cell culture
Mouse neuroblastoma cells (N2a, ATCC CCL-131) and
mouse embryonic fibroblast cells (BALB/c 3T3, ATCC
clone A31) were purchased from American Type Culture
Collection (ATCC; MD, USA). N2a cells were cultured
in Eagle’s minimum essential medium (MEM) with L-
glutamine (PAA) supplemented with 10% (v/v) heat-
inactivated foetal bovine serum (PAA), 100 U/ml penicillin,
and 100 μg/ml streptomycin. 3T3 fibroblasts were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) with L-glutamine (high glucose at 4.5 g/l)
supplemented with 10% FBS. All the cells were maintained
at 37°C and 5% CO2 in a humidified atmosphere. N2a cells
were subcultured at 3 – 4 days intervals while 3T3 cells
were routinely passaged every 2 – 3 days. For preserva-
tion, the cells were frozen at −70°C liquid nitrogen in
complete medium supplemented with 5% (v/v) dimethyl
sulfoxide (DMSO; Sigma) as a cryoprotecting agent.
Preparation of mushroom extracts
The fresh fruiting bodies of P. giganteus, P. pulmonarius,
H. erinaceus, and G. frondosa were sliced, frozen and
then freeze-dried for two days. The freeze-dried fruiting
bodies were then ground to powder and kept at 4 - 8°C.
For aqueous extraction, the freeze dried powder was
soaked in distilled water (1:20, w/v) at room temperature
and 200 rpm in a shaker for 24 h. The mixture was then
double boiled in water bath for 30 min, cooled and then
filtered (Whatman No. 4). The resulting aqueous extracts
were freeze-dried and kept at −20°C prior to use. The
process was repeated for the freeze-dried powder of C.
militaris and L. rhinocerotis sclerotia. For ethanol extrac-
tion, the freeze dried powder was soaked in 95% ethanol
at room temperature for three days and the process was
repeated three times. The solvent was then evaporated
using a rotary evaporator (Eyela N-1000, USA) to give a
brownish viscous extract.
Neurite outgrowth assay
N2a cells were seeded in 24-well culture plate at an initial
density of 5,000 cells per well containing complete growth
medium (1 ml/well) and incubated overnight. Concentra-
tions of NGF ranging from 5–100 ng/ml (w/v) were tested
to determine the optimum concentration that stimulates
maximum neurite outgrowth. The optimum concentra-
tion was then used as a positive control throughout the
subsequent assays. Aqueous and ethanol mushroom ex-
tracts were stocked at 10 mg/ml and were subsequently
dissolved in sterile distilled water or DMSO, to the appro-
priate concentrations. The final concentration of DMSO
in the assays was 0.1 - 0.25%. To induce cell differenti-
ation, the complete medium was carefully replaced with
5% serum medium before exposure to mushroom extracts
at 10–50 μg/ml. Cells with medium only served as a
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at 37°C, 95% air and 5% CO2 to observe neuritogenesis
activity, if any. Curcumin, G. biloba and L. barbarum
extracts were also tested to compare the neurite outgrowth
activities with those of mushroom extracts.
Quantification of neurite bearing cells
Five random fields (100 – 200 cells/well) were exam-
ined in each well by using a phase contrast microscope
(20× magnifications) equipped with QImaging Go-3
camera (QImaging, Canada). Neurite length was measured
in at least 30 cells in randomly chosen fields by using image
processor system Image-Pro Insight (MediaCybernetics,
MD). The number of neurite outgrowths, defined as axon-
like extensions that were double or more than the length of
the cell body diameter was recorded. The percentage of
neurite bearing cells (%) is the number of neurite bearing
cells divided by the total number of cells in a field and
then multiplied by 100%. At least three independent
experiments were conducted and results were expressed
as mean ± standard deviation (S.D).
Fluorescence immunocytochemistry study
The axon-like extensions were confirmed as neurite out-
growth by immunofluorescence study. N2a cells were
seeded in 12-well μ-dishes (ibidi, Martinsried, Germany)
and were exposed to treatments for 48 h. The cells were
fixed with 4% paraformaldehyde in PBS (pH 7) for 20 min.
After two washes with PBS, the cells were incubated with
rabbit anti-neurofilament 200 polyclonal antibody (1:80 in
10% sheep serum as blocking buffer) for 1 h. The cells
were washed and then incubated in a mixture of fluores-
cein isothiocyanate (FITC)-conjugated secondary antibody
and sheep anti-rabbit IgG (1:160 in blocking buffer) for
2 h at room temperature in the dark. The cells were
then washed three times. 4'-6-diamidino-2- phenylindole
(DAPI) was used to counter stain the nuclei. Images were
observed under a fluorescent microscope (Nikon Eclipse
80i microscope).




N2a and 3T3 cells (1 × 104) per well were seeded in 96-well
plates. After incubation for 24 h, different concentrations
of mushroom extracts (0 – 5 mg/ml) dissolved in phenol
red free culture medium were added to each well. The
samples were incubated for 24 h at 37°C under humidified
atmosphere of 5% CO2 and 20 μl MTT (5 mg/ml) was
added to each well. The crystal dyes which were up-taken
by the cells were then dissolved with DMSO. Absorbance
was measured at 570 nm in a microplate reader (Tecan,
Austria) using 630 nm as a reference wavelength. Allmeasurements were done in triplicates, and at least
three independent experiments were carried out. To
calculate IC50 values which estimated the concentra-
tion of mushroom extract that caused 50% inhibition
of proliferation (viability) in N2a and 3T3 cells, Probit
analysis was conducted using SPSS 17.0 (SPSS Science
Inc., Chicago, IL).Neutral red uptake assay
Neutral red medium (40 μg/ml) was prepared fresh before
use by diluting the neutral red stock (4 mg/ml) with
phenol red free culture medium. Neutral red medium
was centrifuged at 1800 rpm for 10 min to remove any
precipitated dye crystals before use. After cell seeding
and treatment (0 – 5 mg/ml), the medium was discarded
and replaced with equal amount of neutral red medium to
each well of the plate. The plate was then incubated for
2 h. The neutral red medium was then removed and
the cells were washed quickly with adequate amount of
PBS. A total of 100 μl of neutral red solubilising solution
(1% acetic acid in 50% ethanol) was added to each well
and allowed to stand for 10 minutes at room temperature
until the neutral red extracted from the cells reached a
homogeneous solution. The absorbance at a wavelength
of 540 nm with 690 nm of background absorbance was
spectrophotometrically measured (Tecan, Austria). The
experiment was repeated at least three different times.Lactate dehydrogenase (LDH) release assay
After cell seeding and treatment with mushroom extracts
(0 – 5 mg/ml), the culture plates were centrifuged at 1500
rpm for 5 minutes and 50 μl of supernatant was then
transferred to a new plate for LDH analysis according to
manufacturer instruction (Sigma). To each well, 100 μl of
LDH mixture solution comprising of LDH assay substrate,
dye and cofactor was added and incubated at room
temperature for 30 min. The reaction was stopped by
adding 10 μl of 1 N HCl to each well. Absorbance was
spectrophotometrically measured at 490 nm with back-
ground absorbance at 690 nm. Triton X-100 (0.5%,
Scharlau) was used as a positive control and was thus
set to 0% viability representing a 100% cell death.Statistical analysis
All the experimental data are expressed in mean ± standard
deviation (S.D). Statistical differences between groups
were analysed and calculated by one-way analysis of
variance (ANOVA) from at least three independent
experiments. This was followed by Duncan's multiple
range tests. P < 0.05 was considered to be significant
between groups.
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The effects of NGF on neurite outgrowth activity in
N2a cells
Nerve growth factor induced neurite outgrowth of N2a
in a dose-dependent manner (Figure 1). After 48 h of
NGF stimulation, the percentage of neurite bearing cells
increased significantly (p < 0.05) to 26.1 ± 1.8% in N2a
cells treated with 50 ng/ml NGF when compared to
negative control (7.6 ± 2.5 %). At 60 ng/ml of NGF, the
percentage of neurite bearing cells significantly decreased
to 12.2 ± 2.1% (p < 0.05). Based on these findings, the
optimised concentration of NGF (50 ng/ml) was selected
for the following experiments as a positive control.
The effects of different mushroom extracts on neurite
outgrowth activity in N2a cells
The positive control (NGF) recorded 26.4 ± 3.6% of
neurite-bearing cells (Figure 2). The extraction yield of
extracts from the mushrooms are summarised in Table 2.
The percentage of neurite bearing cells after treatment
with aqueous extracts of G. lucidum (38.4 ± 4.2%),
L. rhinocerotis (38.1 ± 2.6%), and ethanol extract of
C. militaris (35.8 ± 3.4%)were significantly higher (p < 0.01)
than NGF control by approximately 1.45-, 1.44- and
1.35-fold, respectively. Aqueous extracts of G. frondosa
(33.7 ± 1.5%) and P. giganteus (33.4 ± 4.6%) were also
shown to induce significantly (p < 0.05) higher neurite
bearing cells compared to the NGF control. Meanwhile,
the aqueous extracts of L. rhinocerotis mycelium,
H. erinaceus, G. neo- japonicum, P. pulmonarius, as
well as ethanol extracts of H. erinaceus, P. pulmonarius
and P. giganteus showed varied neurite outgrowth stimula-
tory effects with average neurite bearing cells ranging from
26.4 ± 5.4% to 29.6 ± 2.2%. Further, these extracts showed
no significant difference when compared to NGF control
(p > 0.05). Among the plant extracts tested, wolfberryFigure 1 Effects of different NGF concentrations (5 – 100 ng/ml)
on stimulation of neurite outgrowth using differentiating N2a
cells as an in vitro model. The results shown represent the
mean ± SD; n = 3. Means not sharing a common letter were
significantly different at p < 0.05.extract did not show any neurite outgrowth activity.
The percentage of neurite bearing cells obtained after
treatment with 20 μg/ml of ethanol extract of G. biloba
(30.3 ± 2.5%) was better than curcumin which gave
26.4 ± 5.4% at 20 μg/ml. The five different mushroom
extracts (G. lucidum, L. rhinocerotis, P. giganteus,
G. frondosa and C. militaris) each at 20 μg/ml were
selected for neurofilament staining.
The mean diameter of N2a cell body was found to be
19.45 ± 0.72 μm (Figure 3). To qualify as a “neurite”, the
axon-like extension needs to be double or more than the
cell body length of N2a. The average neurite length of
NGF-stimulated cells was 78.58 ± 18.6 μm, which is
approximately 4-time longer than the cell body. Cells
treated with aqueous extract of G. lucidum were found to
develop the longest mean neurite length i.e. 121.51 ± 28.6
μm (6.25-time longer than cell body), followed by aqueous
extract of P. giganteus which recorded mean neurite
length of 116.72 ± 29.5 μm (5.99-time longer than cell
body). Figure 4 shows the morphology of differentiat-
ing N2a cells with neurites after 48 h of treatment
with 50 ng/ml NGF (a) and 20 μg/ml of aqueous ex-
tracts of G. lucidum (b), L. rhinocerotis (c), P. giganteus
(d) and G. frondosa (e); as well as ethanol extract of
C. militaris (f ).Immunofluorescence staining of neurofilament
Neurofilament belongs to a class of intermediate filament
found in neuronal cells that provides specific support
for axons. There is a direct relationship between neurite
outgrowth and neurofilament expression as neurofilament
protein levels increase with differentiation of cell lines
[23]. Figure 5 shows the immunocytochemical labeling of
neurons. The expression of neurofilament protein during
neurite outgrowth was stained green while nuclei were
stained blue.The cytotoxic effects of mushroom extracts on 3T3 and
N2a by using MTT, NRU and LDH release assay
Table 3 shows the results of cytotoxicity screening of
mushroom and plant extracts to N2a cells and 3T3
fibroblasts. The cytotoxicity determination are expressed
as IC50 values, which is the concentration resulting in
50% inhibition of cell growth and proliferation after 24 h
exposure. All the extracts of mushrooms and plants did
not show cytotoxic effects to the two tested cell lines
(IC50 ≥ 1 mg/ml in all cases). Three cytotoxicity endpoints
were used in this experiment, which were MTT, NR
uptake assay and LDH release assay. Interestingly, IC50
determined by NRU test and LDH test was higher than
that of MTT. In general term, the ethanol extracts
showed lower IC50 too.
Figure 2 Percentage of neurite bearing cells after treatment of different mushroom and plant extracts. * p < 0.05, ** p < 0.01 versus the
positive control (NGF). (S) = sclerotium, (M) = mycelium.
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Eight species of medicinal mushrooms were investigated
and categorised into two groups: culinary and non-
culinary. The former group represents mushrooms that
can be used for culinary purposes like preparing meal
and cooking, especially from the fruiting bodies. This
group (culinary-medicinal mushrooms) comprised of
P. giganteus, P. pulmonarius, H. erinaceus, and G.
frondosa. Medicinal mushrooms of no culinary properties
are appreciated for their pharmacological merits and areTable 2 Extraction yield of aqueous and ethanol extracts
from the studied mushrooms
Mushrooms Extract Yield (%, w/w)
Lignosus rhinocerotis (S) Aqueous 3.56











Lycium barbarum (wolfberry) Aqueous 9.76
Gingko biloba Ethanol n.d
(S) = sclerotium, (M) = mycelium. n.d. = not determined.not cooked as a meal. The fruiting bodies or sclerotia are
often handpicked, ground to powder and subjected to
various extraction methods before being used as a trad-
itional medication [24]. L. rhinocerotis, G. lucidum, G.
neo-japonicum, and C. militaris are non-culinary medi-
cinal mushrooms.
Ganoderma lucidum (also known as Lingzhi in Chinese
or Reishi in Japanese) has been widely investigated for its
potential therapeutic benefits and longevity. Our results
showed that aqueous extract of G. lucidum promoted
neuritogenesis in N2a cells with 38.4 ± 4.2% of neuriteFigure 3 The mean neurite length of N2a treated with different
mushroom extracts at 20 μg/ml. The results shown represent the
mean ± SD; n = 3. Means not sharing a common letter were
significantly different at p < 0.05. S = sclerotium, aq = aqueous,
EtOH = ethanol.
Figure 4 Phase-contrast photomicrographs showing the effects of (a) NGF, (b) G. lucidum, (c) L. rhinocerotis, (d) P. giganteus, (e)
G. frondosa, and (f) C. militaris on the morphology of differentiating N2a cells after 48 h. Untreated cells serve as control (g) and only
contained 5% FBS as vehicle. Arrows indicate typical neurites of N2a. Scale bar represents 20 μm. Photomicrographs of representative
microscope fields were taken with a 20× objective.
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[25] who showed that Ganoderma extract contained NGF-
like compounds that mediated the neuronal differentiation
and elongation of rat pheochromocytoma (PC12) cells.
The Ganoderma neuroactive constituents that accounted
for neurite outgrowth activity are triterpenoids, such as
lucidenic acid [26], 7-oxo-ganoderic acid Z, ganolucidic
acid A, methyl ganoderic acid A, ganoderic acid S1,
and 4,4,14α-trimethyl-5α-chol-7,9(11)-dien-3-oxo-24-
oic acid [27]. Further, the water-soluble polysaccharides
of G. lucidum were shown to significantly (p < 0.05)
reduce neuronal cell death and apoptosis of rat primary
cortical neurons (model of brain cerebral ischemia) induced
by oxygen/glucose deprivation treatment [19]. Ganoderma
extracts may also provide mitigation to Parkinson’s disease
as it was shown to prevent dopaminergic neuron degener-
ation by attenuating the pro-inflammatory response of
microglial cells [28].
The tiger milk mushroom, L. rhinocerotis has been
described as the national treasure of Malaysia as thisFigure 5 Immunocytochemical staining of neurofilament in N2a cells
P. giganteus, (e) G. frondosa, and (f) C. militaris, and untreated cells as
200 kD labeled with FITC stains neuronal cells green. Scale bar represents 2
representative microscope fields were taken with a 20× objective.macrofungus is rare and is often used as folk remedy to
treat a variety of diseases. Consistent with our previous
study [8], the sclerotia of L. rhinocerotis improved
neurite outgrowth in N2a. Interestingly, in the present
study, the sclerotial extract (38.4 ± 4.2% of neurite
bearing cells) performed better than the mycelial extract
(27.2 ± 2.9%). However, the active components in L.
rhinocerotis that play the role in neurite outgrowth activity
need further investigation. Lee et al. [15] highlighted that
the protein or carbohydrate/protein complex of the cold
water scerotial extract (4°C) is responsible for the anti-
proliferative activity against human breast and lung car-
cinoma. In this study, a hot water extraction approach was
employed and we hypothesise that polysaccharides or
triterpenoids rather than peptides are involved in the
neurite outgrowth stimulatory activity of L. rhinocerotis.
Wild Pleurotus giganteus has been reported to be
consumed by the indigenous tribes of Semai, Temuan,
and Jakun in Malaysia [29]. This wild mushroom has been
successfully domesticated for large scale production and istreated with (a) NGF, (b) G. lucidum, (c) L. rhinocerotis, (d)
control (g). DAPI stains for nuclei blue, while anti-neurofilament
0 μm. Arrows indicate neurite outgrowth. Photomicrographs of
Table 3 IC50 values obtained by using different cytotoxicity assays- MTT, NRU and LDH release
Mushroom/Plant Species Extracts Neuroblastoma 2a cells 3T3 embryonic fibroblast
IC50 (mg/ml) after 24 h IC50 (mg/ml) after 24 h
MTT NRU LDH MTT NRU LDH
Culinary/medicinal
mushroom
Pleurotus giganteus Aqueous 4.07 ± 0.67e 6.95 ± 1.00g - 2.16 ± 0.05c 2.67 ± 0.47d -
Pleurotus pulmonarius 2.85 ± 0.06cd 2.13 ± 0.87cdef - 1.75 ± 0.14bc 2.60 ± 0.55d -
Lignosus rhinocerotis
(sclerotium)
3.27 ± 0.77d 2.72 ± 0.65ef - 5.63 ± 0.06e 5.93 ± 0.05f -
Lignosus rhinocerotis 2.43 ± 0.12c 1.75 ± 0.18abc - 5.23 ± 0.17e 5.60 ± 0.1f -
(mycelium)
Hericium erinaceus 2.60 ± 0.52cd 2.85 ± 0.56e - 3.43 ± 0.29d 3.53 ± 0.06e -
Ganoderma lucidum 1.35 ± 0.03a 1.52 ± 0.17ab 2.20 ± 0.52ab 1.19 ± 0.06ab 1.35 ± 0.02ab 1.50 ± 0.08a
Ganoderma
neo-japonicum
1.17 ± 0.006a 1.11 ± 0.03a 2.00 ± 0.53ab 1.47 ± 0.37ab 1.78 ± 0.56bc 1.58 ± 0.44a
Grifola frondosa 2.72 ± 0.08cd 4.60 ± 1.10f - 6.67 ± 0.87f 7.60 ± 0.1g -
Pleurotus giganteus Ethanol 2.43 ± 0.10c 2.81 ± 0.15e 5.8 ± 0.10c 1.66 ± 0.56bc 1.96 ± 0.42c 1.73 ± 0.48a
Pleurotus pulmonarius 2.30 ± 0.72bc 2.64 ± 0.16def 2.53 ± 0.96bc 1.27 ± 0.06ab 1.48 ± 0.05abc 1.67 ± 0.12a
Hericium erinaceus 2.47 ± 0.50c 1.61 ± 0.51ab 2.10 ± 0.72ab 1.31 ± 0.03ab 1.84 ± 0.57bc 1.47 ± 0.31a
Cordyceps militaris 1.65 ± 0.015ab 1.81 ± 0.10abcd 2.37 ± 0.21b 1.02 ± 0.08a 1.10 ± 0.02a 1.40 ± 0.29a
Medicinal plant Lycium barbarum Aqueous 4.37 ± 1.00e 6.96 ± 0.73g - 8.40 ± 0.72g 7.86 ± 0.06g -
Gingko biloba Ethanol 1.56 ± 0.08ab 1.66 ± 0.11ab 1.43 ± 0.39a 1.56 ± 0.58abc 1.37 ± 0.07ab 1.78 ± 0.07a
Curcumin Compound 1.13 ± 0.01a 1.15 ± 0.01a 1.30 ± 0.16a 1.16 ± 0.06ab 1.23 ± 0.03ab 1.60 ± 0.22a
The data represent the mean ± SD of three determinations. Means not sharing a common letter were significantly different at p < 0.05.
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erties of P. giganteus are comparatively little as compared
to P. pulmonarius (grey oyster mushroom). Recently
P. giganteus (synonyms: Lentinus giganteus and Panus
giganteus) was shown to have in vivo hepatoprotective
effect in rat [13] and in vitro neuritogenic effects in
PC12 cells [10]. On-going studies aimed at isolating and
identifying the chemical constituents of the P. giganteus
fruiting bodies indicate the presence of phenolics (caffeic
acid and cinnamic acid), organic acid (succinic acid) and
triterpenoids (unpublished data). The compounds may
work synergistically and accounted for neuritogenesis.
Cordyceps militaris is a parasitic fungus that colonises
moth larvae (Lepidoptera) and has been valued in Trad-
itional Chinese Medicine for more than 2000 years. The
major bioactive components in C. militaris include adeno-
sine, cordycepin and polysaccharides [30]. Our finding is
in agreement with the work by Lee et al. [21] where
methanol extract of C. militaris was shown to significantly
reverse the scopolamine-induced deficit in memory of rat
and improve neurite outgrowth in N2a. Similar to our
results, lysophosphatidylethanolamine isolated from G.
frondosa (Maitake) was also reported to induce neuronal
differentiation in PC12 cells, causing up-regulation of
neurofilament M expression of PC12 cells [22].
It is well known that N2a cells, upon the withdrawal
of serum, differentiate and elaborate neurites [31,32].This well-defined neuronal model is often employed for
studies relating to neuronal differentiation [33]. It is also
a popular cell line in studying neurotoxicity as the brain
is a first target in situations such as ageing and neurode-
generative diseases [34]. NGF is the most appropriate
positive control in neurite outgrowth assays as its role in
neural development have been characterised extensively
as supported by Sofroniew et al. [35]. The therapeutic
application of neurotrophins like nerve growth factor
(NGF) is not possible as NGF cannot penetrate the
blood–brain barrier. Studies indicate that lower-molecular-
weight molecules may be a promising alternative for
therapeutic intervention, for example, α-phenyl-N-tert-
butylnitron [36]. However, most of the experiments testing
natural products have been conducted in vitro, and few
studies evaluated these compounds in the brain in vivo.
Our previous study showed that aqueous extract of P.
giganteus induced neuronal differentiation of PC12 cells
via the activation of extracellular signal-regulated kinase
(ERK) and phosphatidylinositol-3-kinase-Akt (PI3K/Akt)
signaling pathways [10]. In fact, the most studied path-
way controlling the consolidation of neurites involves
signaling through neurotrophin receptors to a Ras-
dependent, mitogen-activated protein kinase (MAPK)
cascade [33]. At present, the precise neuritogenic signal
transduction pathway involved in the actions of NGF,
serum withdrawal, and the mushroom extracts is yet to be
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prising of neuroactive polysaccharides or triterpenoids)
under certain condition (serum deprivation) participate in
triggering NGF signals, hence activating the downstream
neuronal responses to axonal growth [37].
It is important that functional and health food remedies
recommended for the prevention or treatment of diseases
undergo safety assessment. Today, a number of natural
products with potential biomedical application are being
launched, although some could be potentially toxic when
ingested at high doses or in combination with other medi-
cations [38]. Our results indicated that no cytotoxicity was
detected for the concentrations tested. Notably, ethanol
extract of C. militaris showed the lowest IC50 (p < 0.05)
value against 3T3 fibroblast. Similarly, curcumin although
was reported beneficial in neuroprotection [39], the IC50
value detected against N2a was the lowest by means of
MTT, NRU and LDH assays. Elsewhere, in vivo toxicity
evaluation of Ganoderma boninense (Pat.) was carried out
[40] and a significant toxicity (IC50 = 640 μg/ml) against
Artemia salina (brine shrimp) was demonstrated after 24
h. However, Ganoderma extract is granted safe on short-
term exposure. Conversely, in vivo toxicity profiling of
total triterpene fraction from G. lucidum against Swiss
albino mice showed that ganoderma triterpenes did
not possess significant toxicity [41] and administration
of G. lucidum β–glucan (2000 mg/kg body weight/day)
to Sprague Dawley rats did not cause toxicological
abnormality [42]. Mutagenicity studies by means of
Salmonella typhimurium also did not reveal any geno-
toxicity. Meanwhile, sub-acute toxicity study of the
sclerotial powder of L. rhinocerotis by using rat model
showed no treatment-related toxicity at 1000 mg/kg
[43]. Taken together, beneficial mushroom extracts
hardly exert any significant toxicity.
We have chosen more than one cytotoxicity assay
namely MTT, NRU and LDH release assay to determine
in vitro cell viability in order to increase the reliability of
the results obtained and also to avoid over- or underestima-
tion of the mushroom or plant toxicity. The mechanisms of
the chosen assays are different. While MTT is based on the
enzymatic conversion of MTT in the mitochondria, NRU
assay is based on the dye uptake capability by lysosomes
[44]. Both served as colorimetric assays, whereby viable and
uninjured cells stain blue and red, for MTT and NRU
assays, respectively. LDH release assay, on the other hand
is based on the release of the enzyme into the culture
medium after the disruption of cell membrane [45]. It is
noteworthy that the toxicity profiles detected by the three
different assays generally followed a similar trend although
some results were not in agreement. For instance, no IC50
values were recorded for some mushroom extracts by
using LDH assays, suggesting that LDH may be the least
sensitive method among the three.Conclusions
The extracts of G. lucidum, L. rhinocerotis, P. giganteus,
G. frondosa and C. militaris showed potential in promot-
ing neurite outgrowth of differentiating N2a cells. The
synergism of the various active entities in these mushroom
extracts may be responsible for the neurite outgrowth
activity and further experiments are warranted to isolate
and identify the compounds. The signaling pathways
involved is yet to be elucidated but based on our previous
results, among other possibilities, phosphorylation and
activation of the ERK and Akt may be involved. This study
also showed the absence of embryotoxic and neurototoxic
effects of the various mushroom extracts in 3T3 and N2a
cells, respectively.
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